Tranquility Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,887
Closed -$251K 176
2020
Q3
$251K Sell
2,887
-985
-25% -$85.3K 0.21% 124
2020
Q2
$338K Sell
3,872
-1,005
-21% -$86.8K 0.32% 97
2020
Q1
$402K Buy
4,877
+245
+5% +$21.9K 0.46% 62
2019
Q4
$439K Hold
4,632
0.4% 81
2019
Q3
$403K Sell
4,632
-70
-1% -$6.29K 0.43% 76
2019
Q2
$429K Buy
+4,702
New +$398K 0.46% 68

Other funds holding NVS

Tranquility Partners's NVS Position: Q4 2020 in Review

Tranquility Partners sold out of Novartis (NVS) in Q4 2020, closing a stake of 2,887 shares — an estimated $251K sold.

Tranquility Partners first reported a position in NVS in Q2 2019 and held it in 6 quarters. The position peaked at $439K in Q4 2019. 1,176 funds tracked by Wall St. Rank hold NVS as of Q4 2020.

  • Tranquility Partners reported no remaining Novartis position as of Q4 2020 after selling out during the quarter.
  • Tranquility Partners sold 2,887 Novartis shares in Q4 2020, an estimated $251K.
  • Tranquility Partners first reported a position in Novartis in Q2 2019 and held it in 6 quarters.
  • Tranquility Partners's Novartis position peaked at $439K in Q4 2019.
  • 1,176 funds tracked by Wall St. Rank held Novartis as of Q4 2020.

Based on Tranquility Partners's 13F filing for Q4 2020, filed 29 Jan 2021.